News

The approval of the first malaria treatment for newborns and young infants could lead to imminent widespread use in Africa, ...
The newly approved medication, Coartem Baby, is a combination of two antimalarials. It is a lower dose version of a tablet ...
Switzerland’s drug authority has granted approval for the first malaria medication specifically designed for infants and ...
A sweet cherry flavour, including in breast milk, and easily dissovleable drug is now approved for the treatment of malaria ...
Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global ...
Novartis has received approval in Switzerland for Coartem Baby, the first drug designed specifically to treat malaria in ...
Novartis said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat ...
Novartis shares climb on strong Cosentyx sales, franchise growth, and a new malaria drug approval despite political risks.
A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young ...
The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic.
Novartis has received approval for Coartem Baby, the world's first malaria treatment specifically for newborns and young ...
In a historic move, Swissmedic has approved Coartem Baby, the first malaria treatment specifically for newborns and young ...